ABSTRACT -We describe a case of GNAO1-associated epilepsy and chorea in a patient with a de novo pathogenic mutation. This patient is unique in being the first reported male with this phenotype, and we propose that this genetic variant may represent a mutation hotspot that characterizes a unique phenotype. This 5.2-years-old boy presented with seizures, chorea, and severe global developmental delay. Brain imaging showed progressive diffuse cerebral atrophy. EEG monitoring revealed multifocal and diffuse discharges, along with generalized-onset seizures. Genetic testing found a de novo pathogenic variant in the GNAO1 gene (c.607G>A; p.Gly203Arg). A review of the literature showed two other patients with similar phenotype and the same genetic variant. In contrast, other patients with neurological involvement had private mutations in the GNAO1 gene. The neurological phenotypes associated with GNAO1 mutations appear to lie on a spectrum, and it is possible that the c. 607G>A (p.Gly203Arg) Massively parallel gene sequencing for comprehensive disease-specific panels and whole-exome sequencing are increasingly contributing to the diagnosis and improved understanding of the biology of epilepsies (Ottman et al., 2010) . In 2013, Nakamura et al. tested 367 individuals and demonstrated pathological consequences of variants in the GNAO1 gene in four of them (Nakamura et al., 2013) . The GNAO1 gene, which encodes the G␣ o subunit of guanine-binding proteins (G proteins), was reported to be associated with epileptic encephalopathy. GNAO1-associated neurological phenotypes remain insufficiently characterized and have been reported to include epileptic encephalopathy (n=5), epileptic encephalopathy with movement disorder (n=6), and only movement disorders (n=3) (Nakamura et al., 2013; Euro et al., 2014; Law et al., 2015; Talvik et al., 2015; Kulkarni et al., 2016; MarceGrau et al., 2016; Saitsu et al., 2016) . We describe a patient with GNAO1-associated epilepsy and chorea who is unique in being the first male with this phenotype. Additionally, we propose that the particular genetic variant (c.607G>A, p.Gly203Arg) found in our patient probably represents a mutation hotspot and characterizes a distinct phenotype. suffusion, and a drop in SpO 2 detected by home oximetry. He also developed episodes of abnormal movements at around 5 months of age, consisting of kicking and/or thrashing movements of the arms and legs which flowed from one body part to another, sometimes associated with heavy breathing (see video sequence). The episodes typically lasted 1.5-2 hours and occurred daily. Parents distinguished these episodes from seizures based on a longer duration and no decrease in SpO 2 . He was delivered by emergency C-section at 37 weeks of gestation done for poor progress of labour, but did not have any problems at birth. His development had always been globally delayed. He had never been able to lift his head while supine, though at around 3-4 months age, he might reach out for toys if they were brought within his visual field and could partially track the objects horizontally. Also, before the age of 3 months, he was able to swallow liquids and semi-solids, to some extent. Subsequently, his swallowing progressively worsened which necessitated placement of a feeding tube. Interictal epileptiform discharges can be seen asynchronously in the left frontal, left anterior temporal, right frontal, and right anterior temporal head regions, as well as diffusely bilaterally. Low-amplitude paroxysmal fast activity can also be seen in the right posterior temporal head region. Ictal onset (middle panel; arrows) was characterized by a diffuse sharp wave with central/parietal amplitude emphasis, followed by diffuse attenuation and superimposed low-amplitude fast activity, followed by 2-3 Hz sharply contoured polymorphic delta activity in a similar distribution. The seizure ends abruptly after 22 seconds (lower panel; arrow) with return of the interictal pattern. Clinically, the patient opened his eyes, had tonic extension of all four extremities (predominantly the legs), and a few clonic jerks of the arms towards the end of the seizure. abduction, was noted on spontaneous eye movement. Features of pseudo-bulbar palsy (stiff tongue, brisk jaw, and gag reflexes) were also noted. Muscle bulk and tone were diffusely decreased, though spontaneous anti-gravity movements in all extremities were noted. He also had dystonia of both upper extremities and perioral dyskinesia. Serial brain imaging performed at four-year interval showed progressive diffuse atrophy involving the cerebral hemispheres (more prominent in the left hemisphere) and cerebellum, non-specific T2/FLAIR hyperintense foci in white matter, and normal spectroscopy ( figure 1) . EEGs performed at the time of onset of initial seizures were reported to show multifocal interictal discharges. EEG monitoring at the time of presentation also showed a slow background and bilateral multi-focal interictal epileptiform discharges. Also, multiple daily seizures were identified, occurring predominantly during sleep, with eye opening, tonic stiffening of all four limbs (sometimes asymmetric), and semi-rhythmic jerking of arms (left>right). Ictal onset was characterized by generalized 1.5-2-Hz discharges with frontal amplitude emphasis. The seizures were brief, lasting 20-25 seconds, and were unrecognized by parents ( figure 2) 
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Case study
This 5.2-year-old boy presented with seizures, abnormal movements, and developmental delay. Seizures started at around 1 month of age and consisted of behavioural arrest and staring, lasting for a few seconds, and increased drooling, above baseline. At around 1 year of age, his seizure semiology changed to eyes being wide open, unresponsiveness, facial 2010 2011 2015 Figure 1 . Serial brain magnetic resonance imaging performed over four years demonstrating interval progressive volume loss involving cerebral hemispheres (more prominent in the left hemisphere). There was also volume loss in the cerebellum (more pronounced on the left), minimal non-specific T2/FLAIR hyper-intense foci in the white matter, and normal spectroscopy (not shown).
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abduction, was noted on spontaneous eye movement. Features of pseudo-bulbar palsy (stiff tongue, brisk jaw, and gag reflexes) were also noted. Muscle bulk and tone were diffusely decreased, though spontaneous anti-gravity movements in all extremities were noted. He also had dystonia of both upper extremities and perioral dyskinesia. Serial brain imaging performed at four-year interval showed progressive diffuse atrophy involving the cerebral hemispheres (more prominent in the left hemisphere) and cerebellum, non-specific T2/FLAIR hyperintense foci in white matter, and normal spectroscopy (figure 1). EEGs performed at the time of onset of initial seizures were reported to show multifocal interictal discharges. EEG monitoring at the time of presentation also showed a slow background and bilateral multi-focal interictal epileptiform discharges. Also, multiple daily seizures were identified, occurring predominantly during sleep, with eye opening, tonic stiffening of all four limbs (sometimes asymmetric), and semi-rhythmic jerking of arms (left>right). Ictal onset was characterized by generalized 1.5-2-Hz discharges with frontal amplitude emphasis. The seizures were brief, lasting 20-25 seconds, and were unrecognized by parents (figure 2). 
Discussion
Pathogenic variants in GNAO1 were recognised as a cause of epileptic encephalopathy based on testing of a large cohort of individuals with epilepsy and structural modelling to demonstrate molecular consequences of genetic variants (Nakamura et al., 2013) . Based on available reports, it is possible to classify the clinical presentations into three somewhat overlapping phenotypes with considerable genetic heterogeneity (table 1) . These phenotypes include: epileptic encephalopathy (typically early infantile onset with suppression-burst pattern on EEG), drug-resistant epilepsy (with/without epileptic encephalopathy) with movement disorders (chorea, athetosis, dystonia, stereotypies), and chorea/athetosis without seizures. Although our patient is the first male with GNAO1-associated epileptic encephalopathy and chorea, given the small number of patients reported with this phenotype it is unclear if there is a female preponderance or merely a sampling bias. On reviewing this patient together with other published cases, it appears that the c.607G>A variant probably represents a mutation hotspot and may characterize a distinct phenotype. This genetic variant (c.607G>A) has been documented in three individuals, whereas all other reported patients with GNAO1-associated epilepsy had distinct private variants. The c.607G>A variant presents with multiple seizure types including partial tonic-clonic Figure 3 . Alignment of amino acid sequences from vertebrate orthologs of GNAO1 demonstrating the evolutionary conservation of the GNAO1 variant G203R. The variant occurs in a region predicted to be a GTP binding site based on the sequence. (Huff et al., 1985) . The substituted residue corresponding to Gly203 of human G␣ o is located within the highly conserved switch II region (figure 3), responsible for activation of downstream effectors upon GTP binding. Nakamura et al. showed that p.Gly203Arg substitution causes steric hindrance between the arginine side chain and the switch I region and/or GTP, destabilizing the GDP + AlF 4 − bound G␣ effector complex (Nakamura et al., 2013) . This was shown to affect norepinephrine (NE)-induced calcium currents in NG108-15 neuronal cells (a hybrid cell line formed by Sendai virus-induced fusion of the mouse neuroblastoma clone N18TG-2 and the rat glioma clone C6 BV-1) (Nakamura et al., 2013) . Under conditions of impaired GABAergic inhibition, activation of G-protein coupled ␣ 2 adrenergic receptors (AR) on pyramidal cells by NE was reported to decrease the frequency of spontaneous epileptiform bursts in the rat hippocampal CA3 region (Jurgens et al., 2007) . This effect has been shown to use a ␣ 2A AR/G␣ o protein-mediated pathway under strong inhibitory control by regulators of G-protein signalling (Goldenstein et al., 2009) . Alterations in this mechanism resulting from G␣ o variants has been proposed as a potential basis for seizures in GNAO1-associated epilepsy. This also led to speculation that AEDs with calcium channel modulating properties may have particular efficacy in GNAO1-associated epilepsy (Nakamura et al., 2013) . However, zonisamide, which has a T-type calcium channel blocking property, was ineffective in our patient (Kito et al., 1996) . Epileptic encephalopathies starting in infancy have been traditionally classified into certain electroclinical syndromes based on age of onset and other features (Donat, 1992) . In recent years, advances in imaging, metabolic, and genetic investigations have elucidated the aetiology for some patient subgroups within these syndromes. We would emphasize co-existent movement disorders, particularly choreoathetosis, as a clinical clue for GNAO1-associated syndromes. However, the phenotype of seizures and movement disorders presenting in infancy is also seen with intra-uterine stroke, creatine biosynthesis defects, glutaric acidaemia type I, certain other organic acidurias, and rarely in patients with cerebral folate deficiency, STXBP1 variants, or some mitochondrial defects. Often, these disorders can be suspected by history, imaging, and conventional biochemistry. In summary, this case report highlights a probable association of c.607G>A with a clinical syndrome characterized by early-onset encephalopathy, drugresistant epilepsy, and chorea. Though the ubiquity of G-protein coupled mechanisms is probably responsible for multiple neurological manifestations, given the small number of patients, this association should only be recognized as putative and further genotypephenotype correlations will have to await more data.
GNAO1-associated epilepsy and movement disorders

Disclosures.
None of the authors have any conflicts of interest to disclose.
Legend for video sequence
Video showing arrhythmic, asynchronous, and jerky movements of all four extremities and face, which appear to "flow" from one body part to another. Subtle, low-amplitude, tremulous movements are also noticeable, particularly in distal upper extremities. Overall, these features are consistent with choreoathetosis.
